why choose us

300×250 Ad Slot

Research Article: High Expression of Triggering Receptor Expressed on Myeloid Cells Predicts Poor Prognosis in Glioblastoma

Date Published: 2023-05-29

Abstract:
Glioblastoma (GBM) is a malignant glioma that is classified as grade IV according to the World Health Organization (WHO) classification criteria. As GBM is invasive and has no obvious boundary with normal tissue, it cannot be treated by surgery alone. Postoperative radiotherapy and chemotherapy are generally administered, but their overall clinical efficacy and prognosis are still unsatisfactory. The median overall survival (mOS) time of GBM after standardized treatment is only . months. Thus, it is urgent to seek new treatment methods to improve the prognosis of GBM.

Introduction:
Glioblastoma (GBM) is a malignant glioma that is classified as grade IV according to the World Health Organization (WHO) classification criteria. As GBM is invasive and has no obvious boundary with normal tissue, it cannot be treated by surgery alone. Postoperative radiotherapy and chemotherapy are generally administered, but their overall clinical efficacy and prognosis are still unsatisfactory. The median overall survival (mOS) time of GBM after standardized treatment is only . months. Thus, it is urgent to seek…

Read more

300×250 Ad Slot